ZVSA Valuation
Zyversa Therapeutics Inc
$
0.000
- Overview
- Forecast
- Valuation
- Earnings
ZVSA Relative Valuation
ZVSA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ZVSA is overvalued; if below, it's undervalued.
Historical Valuation
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
0.17
P/B
Median3y
-523.12
Median5y
-842.79
-200.75
FCF Yield
Median3y
-210.95
Median5y
-198.84
Competitors Valuation Multiple
The average P/S ratio for ZVSA's competitors is 0.05, providing a benchmark for relative valuation. Zyversa Therapeutics Inc Corp (ZVSA) exhibits a P/S ratio of , which is -100.00% above the industry average. Given its robust revenue growth of %, this premium appears unsustainable.
People Also Watch
XRTX
XORTX Therapeutics Inc
0.835
USD
-2.91%
TTNP
Titan Pharmaceuticals Inc
4.070
USD
-20.73%
SNOA
Sonoma Pharmaceuticals Inc
3.420
USD
-4.89%
ASTI
Ascent Solar Technologies Inc
1.690
USD
-5.59%
BPTH
Bio Path Holdings Inc
0
USD
-201.43%
NCPL
Netcapital Inc
3.190
USD
-2.45%
RETO
ReTo Eco-Solutions Inc
2.500
USD
-11.97%
OST
Ostin Technology Group Co Ltd
0.120
USD
-4.01%
ATXI
Avenue Therapeutics Inc
0
USD
-102.86%
NIVF
NewGenIvf Group Ltd
0.520
USD
-5.11%
FAQ
Is Zyversa Therapeutics Inc (ZVSA) currently overvalued or undervalued?
Zyversa Therapeutics Inc (ZVSA) is now in the Fair zone, suggesting that its current forward PS ratio of NaN is considered Fairly compared with the five-year average of -0.39. The fair price of Zyversa Therapeutics Inc (ZVSA) is between to according to relative valuation methord.
What is Zyversa Therapeutics Inc (ZVSA) fair value?
How does ZVSA's valuation metrics compare to the industry average?
What is the current P/B ratio for Zyversa Therapeutics Inc (ZVSA) as of Jul 27 2025?
What is the current FCF Yield for Zyversa Therapeutics Inc (ZVSA) as of Jul 27 2025?
What is the current Forward P/E ratio for Zyversa Therapeutics Inc (ZVSA) as of Jul 27 2025?